Bioemtech, a leading preclinical CRO & biotech solutions manufacturing company in Greece, has become our 1st corporate partner for the Science-2-Deals, our deals-acceleration program.
By becoming a corporate partner of the Science-2-Deals program, Bioemtech embraces our model to contribute to the deal acceleration journey of Aisthesis Medical, covering advisors & instructors’ expenses and providing advisory assistance where necessary.
We are grateful to Bioemtech for embracing Science-2-Deals on its beginnings, for believing in our vision to create an original deal-focused accelerator and for the hands-on support to the first step of this unique accelerator.
Comentarios